Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions

Head and Neck

Volumn 33, Issue 5, 2011, Pages 719-726

  Liao, Li Jen ^a,b   Hsu, Yi Hsin ^c   Yu, Chuan Hang ^d   Chiang, Chun Pin ^d,e   Jhan, Jing Ru ^c   Chang, Lien Cheng ^c   Lin, Jing Jer ^c   Lou, Pei Jen ^e  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

arecolin; oral cancer; p53; PTTG1; securin

Indexed keywords

ARECOLINE; PROTEIN P53; SECURIN;

ALCOHOL CONSUMPTION; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MOUTH DISEASE; NUCLEOTIDE SEQUENCE; ORAL CARCINOGENESIS; ORAL DYSPLASIA; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SMOKELESS TOBACCO; SMOKING; SQUAMOUS CELL CARCINOMA;

ALCOHOL DRINKING; ARECA; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; HUMANS; MOUTH MUCOSA; MOUTH NEOPLASMS; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SMOKING; TAIWAN; TUMOR MARKERS, BIOLOGICAL;

EID: 79954522651     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21531     Document Type: Article

References (30)

1. Pisani P, Parkin DM, Ferlay J,. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 1993; 55: 891-903. (Pubitemid 24005331)
2. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
3. Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC,. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med 1995; 24: 450-453.
4. Califano J, van der Riet P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 1996; 56: 2488-2492. (Pubitemid 26170679)
5. Forastiere A, Koch W, Trotti A, Sidransky D,. Head and neck cancer. N Engl J Med 2001; 345: 1890-1900. (Pubitemid 33716564)
6. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-717.
7. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996; 2: 682-685. (Pubitemid 26191956)
8. Pei L, Melmed S,. Isolation and characterization of a pituitary tumor-transforming gene (PTTG). Mol Endocrinol 1997; 11: 433-441. (Pubitemid 27147011)
9. Zou H, McGarry TJ, Bernal T, Kirschner MW,. Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science 1999; 285: 418-422.
10. Fang W, Li X, Jiang Q, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008; 6: 32.
11. Fujii T, Nomoto S, Koshikawa K, et al. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis. Hepatology 2006; 43: 1267-1275. (Pubitemid 43980105)
12. Genkai N, Homma J, Sano M, Tanaka R, Yamanaka R,. Increased expression of pituitary tumor-transforming gene (PTTG)-1 is correlated with poor prognosis in glioma patients. Oncol Rep 2006; 15: 1569-1574.
13. Heaney AP, Singson R, McCabe CJ, Nelson V, Nakashima M, Melmed S,. Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet 2000; 355: 716-719. (Pubitemid 30107628)
14. Ito T, Shimada Y, Kan T, et al. Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma. Cancer Res 2008; 68: 3214-3224.
15. Ogbagabriel S, Fernando M, Waldman FM, Bose S, Heaney AP,. Securin is overexpressed in breast cancer. Mod Pathol 2005; 18: 985-990. (Pubitemid 41059961)
16. Saez C, Pereda T, Borrero JJ, et al. Expression of hpttg proto-oncogene in lymphoid neoplasias. Oncogene 2002; 21: 8173-8177. (Pubitemid 35454420)
17. Tfelt-Hansen J, Yano S, Bandyopadhyay S, Carroll R, Brown EM, Chattopadhyay N,. Expression of pituitary tumor transforming gene (PTTG) and its binding protein in human astrocytes and astrocytoma cells: function and regulation of PTTG in U87 astrocytoma cells. Endocrinology 2004; 145: 4222-4231. (Pubitemid 39120571)
18. Wen CY, Nakayama T, Wang AP, et al. Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol 2004; 10: 481-483. (Pubitemid 38325300)
19. Yan S, Zhou C, Lou X, et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res 2009; 69: 3283-3290.
20. Zhou C, Liu S, Zhou X, et al. Overexpression of human pituitary tumor transforming gene (hPTTG), is regulated by beta-catenin /TCF pathway in human esophageal squamous cell carcinoma. Int J Cancer 2005; 113: 891-898. (Pubitemid 40096868)
21. Bernal JA, Luna R, Espina A, et al. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet 2002; 32: 306-311.
22. Kato H, Yoshikawa M, Miyazaki T, et al. Expression of p53 protein related to smoking and alcoholic beverage drinking habits in patients with esophageal cancers. Cancer Lett 2001; 167: 65-72. (Pubitemid 32373270)
23. Shirname LP, Menon MM, Bhide SV,. Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis 1984; 5: 501-503. (Pubitemid 14126717)
24. Wenke G, Rivenson A, Hoffmann D,. A study of betel quid carcinogenesis. 3,3-(Methylnitrosamino)-propionitrile, a powerful carcinogen in F344 rats. Carcinogenesis 1984; 5: 1137-1140. (Pubitemid 14034428)
25. Reibel J,. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003; 14: 47-62.
26. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW,. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 2007; 11: 25-36. (Pubitemid 46070223)
27. Yu R, Lu W, Chen J, McCabe CJ, Melmed S,. Overexpressed pituitary tumor-transforming gene causes aneuploidy in live human cells. Endocrinology 2003; 144: 4991-4998. (Pubitemid 37378414)
28. Loeb LA,. A mutator phenotype in cancer. Cancer Res 2001; 61: 3230-3239. (Pubitemid 32695004)
29. Romero F, Multon MC, Ramos-Morales F, et al. Human securin, hPTTG, is associated with Ku heterodimer, the regulatory subunit of the DNA-dependent protein kinase. Nucleic Acids Res 2001; 29: 1300-1307. (Pubitemid 32229457)
30. Kim DS, Franklyn JA, Smith VE, et al. Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis 2007; 28: 749-759. (Pubitemid 46523373)